QuidelOrtho Corporation

World Rank (Jan-05-2024)

2,991

Market Cap (Jan-05-2024)

4.855 Billion USD

World Rank (Jul-30-2023)

2,609

Market Cap (Jul-30-2023)

5.805 Billion USD

World Rank (Jan-07-2022)

3,198

Market Cap (Jan-07-2022)

5.173 Billion USD

World Rank (Jan-01-2021)

2,110

Market Cap (Jan-01-2021)

7.557 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 884

Headquarters Country

USA

Nasdaq / NYSE Code

QDEL

Market Cap (Mar-08-2026)

1.42

Employee Count

7,000

Employee Count as of Date

As on 2022

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

3,266 Million USD

Annual Net Income in USD

548 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

8,855 Million USD

Total Liabilities in USD

3,921 Million USD

Total Equity in USD

4,934 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Health Care Diagnostics

Company Website

QUIDEL CORPORATION

Yahoo

Yahoo @ Nasdaq

Company Profile

Quidel Corporation is a Diagnostic Healthcare Manufacturer Serving company. It core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development and molecular assay development. The company is delivering a continuum of diagnostic solutions from advanced lateral flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare. The headquarters is in USA.

Annual Results Summary